|
IPA-Telangna, AIDCOC & Pharmexcil to organize ‘Regulator to Facilitator’ symposium on 10th June
|
|
Our Bureau, Hyderabad
June 01 , 2017
|
|
|
The Indian Pharmaceutical Association (IPA) of Telangana State Branch in
association with All India Drugs Control Officers Confederation
(AIDCOC) along with the support of Pharmexcil is organizing a symposium
titled ‘Regulator to Facilitator’ on 10th June 2017 at Radisson Blue
Hotel in Hyderabad.
According to Ravi Uday Bhaskar, Director
General of Pharmexcil, the main objective of the symposium is to help
create a common platform for the senior members from the pharma
industry, officials from the Central drugs and standard control
Organization (CDSCO) and Drug control Administration of Telangana State
who can come together and deliberate on various contemporary issues
pertaining to the pharma industry and regulators.
The symposium
is expected to deliberate on issues pertaining to regulatory changes
that are being incorporated from time to time and at the same time
understand the industry point of view with regard to issues concerning
licensing and renewing of new products etc. “As part of the symposium an
interactive meeting of senior level pharma industry personnel with the
officials of CDSCO and state drug control administration (TSDCA) is
expected to deliberate on various issues concerning pharma industry and
the regulators. This is the best opportunity for the members of pharma
Industry to interact with the regulators on issues relating to various
regulations governing the industry and at the same time the regulators
can understand the industry point of view and both sides can facilitate a
common pathway to resolve issues and enhance quality and at the same
time also help the industry to enable faster growth,” informed Ravi Uday
Bhaskar, Director General of Pharmexcil.
In view of this, the
organizers have chosen the theme of "Regulator to Facilitator" for the
symposium. “The DGCI apart from performing its role of a regulator is
also a facilitator of the Pharma Industry and guides the management of
healthcare system in the country. As the overall combined objective is
to ensure the Indian Companies produce quality medicines at an
affordable price to the patients. We are supporting this symposium to
bring forth clarifications, suggestions, and guidance on regulatory
insights from the state, central regulators and eminent pharma industry
in resolving various issues,” said Uday Bhaskar.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|